Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Febrile mucositis in haematopoietic SCT recipients

Bone Marrow Transplantation volume 43, pages 55–60 (2009)Cite this article

Abstract

We undertook a retrospective analysis of a cohort of 67 patients with multiple myeloma who had received an autologous haematopoietic SCT (HSCT) following high-dose melphalan to explore the impact of mucositis on the systemic inflammatory response. A homogenous group of 16 patients without a documented infection and a group of 30 patients with bacteraemia were identified for whom complete data on neutropenia, an inflammatory response, infectious complications and mucositis were available. All patients showed a similar course of events with an inflammatory response coinciding with the occurrence of significant mucositis, regardless of the presence or absence of infection. The only differences between the two groups were significantly higher maximum C-reactive protein (CRP) levels and lower citrulline levels for patients with bacteraemia, suggesting a causative role for mucositis in the occurrence of bacteraemia. Statistical analysis showed a significant association over time between citrulline levels, to a lesser extent bacteraemia, but not neutropenia, and the inflammatory response measured by CRP. These data suggest that the inflammatory response after conditioning for a HSCT is the result of the chemotherapy-induced mucositis and independent of neutropenia. Though primary inflammation appeared due to mucositis, infections resulting from mucosal barrier injury and neutropenia aggravated the inflammatory response.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Bodey GP, Buckley M, Sathe YS, Freireich EJ . Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328–340.

    Article  CAS  PubMed  Google Scholar 

  2. de Pauw BE, Deresinski SC, Feld R, Lane-Allman EF, Donnelly JP . Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group. Ann Intern Med 1994; 120: 834–844.

    Article  CAS  PubMed  Google Scholar 

  3. Furno P, Bucaneve G, Del FA . Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis. Lancet Infect Dis 2002; 2: 231–242.

    Article  CAS  PubMed  Google Scholar 

  4. Dekker A, Bulley S, Beyene J, Dupuis LL, Doyle JJ, Sung L . Meta-analysis of randomized controlled trials of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor after autologous and allogeneic stem cell transplantation. J Clin Oncol 2006; 24: 5207–5215.

    Article  CAS  PubMed  Google Scholar 

  5. Berghmans T, Paesmans M, Lafitte JJ, Mascaux C, Meert AP, Jacquy C et al. Therapeutic use of granulocyte and granulocyte-macrophage colony-stimulating factors in febrile neutropenic cancer patients. A systematic review of the literature with meta-analysis. Support Care Cancer 2002; 10: 181–188.

    Article  CAS  PubMed  Google Scholar 

  6. From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel. J Infect Dis 1990; 161: 397–401.

    Article  Google Scholar 

  7. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004; 100 (9 Suppl): 1995–2025.

    Article  PubMed  Google Scholar 

  8. Blijlevens NM . Implications of treatment-induced mucosal barrier injury. Curr Opin Oncol 2005; 17: 605–610.

    Google Scholar 

  9. Blijlevens NM, Donnelly JP, de Pauw BE . Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant 2000; 25: 1269–1278.

    Article  CAS  PubMed  Google Scholar 

  10. Marron A, Carratala J, Gonzalez-Barca E, Fernandez-Sevilla A, Alcaide F, Gudiol F . Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer. Clin Infect Dis 2000; 31: 1126–1130.

    Article  CAS  PubMed  Google Scholar 

  11. Costa SF, Miceli MH, Anaissie EJ . Mucosa or skin as source of coagulase-negative staphylococcal bacteraemia? Lancet Infect Dis 2004; 4: 278–286.

    Article  PubMed  Google Scholar 

  12. Ruescher TJ, Sodeifi A, Scrivani SJ, Kaban LB, Sonis ST . The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer 1998; 82: 2275–2281.

    Article  CAS  PubMed  Google Scholar 

  13. Blijlevens NM, Donnelly JP, de Pauw BE . Impaired gut function as risk factor for invasive candidiasis in neutropenic patients. Br J Haematol 2002; 117: 259–264.

    Article  PubMed  Google Scholar 

  14. Elting LS, Shih YC . The economic burden of supportive care of cancer patients. Support Care Cancer 2004; 12: 219–226.

    Article  PubMed  Google Scholar 

  15. MacGregor RR, Beaty HN . Evaluation of positive blood cultures. Guidelines for early differentiation of contaminated from valid positive cultures. Arch Intern Med 1972; 130: 84–87.

    Article  CAS  PubMed  Google Scholar 

  16. Potting CM, Blijlevens NA, Donnelly JP, Feuth T, van Achterberg T . A scoring system for the assessment of oral mucositis in daily nursing practice. Eur J Cancer Care (Engl) 2006; 15: 228–234.

    Article  CAS  Google Scholar 

  17. Blijlevens NM, Lutgens LC, Schattenberg AV, Donnelly JP . Citrulline: a potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy. Bone Marrow Transplant 2004; 34: 193–196.

    Article  CAS  PubMed  Google Scholar 

  18. Crenn P, Vahedi K, Lavergne-Slove A, Cynober L, Matuchansky C, Messing B . Plasma citrulline: a marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology 2003; 124: 1210–1219.

    Article  CAS  PubMed  Google Scholar 

  19. Blijlevens NM, Donnelly JP, DePauw BE . Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients. Bone Marrow Transplant 2005; 36: 703–707.

    Article  CAS  PubMed  Google Scholar 

  20. Tsuji E, Hiki N, Nomura S, Fukushima R, Kojima J, Ogawa T et al. Simultaneous onset of acute inflammatory response, sepsis-like symptoms and intestinal mucosal injury after cancer chemotherapy. Int J Cancer 2003; 107: 303–308.

    Article  CAS  PubMed  Google Scholar 

  21. Mullighan CG, Bardy PG . New directions in the genomics of allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 127–144.

    Article  CAS  PubMed  Google Scholar 

  22. Slavin MA, Grigg AP, Schwarer AP, Szer J, Spencer A, Sainani A et al. A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 40: 157–163.

    Article  CAS  PubMed  Google Scholar 

  23. Offidani M, Corvatta L, Olivieri A, Rupoli S, Frayfer J, Mele A et al. Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. Bone Marrow Transplant 1999; 24: 1079–1087.

    Article  CAS  PubMed  Google Scholar 

  24. Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004; 351: 2590–2598.

    Article  CAS  PubMed  Google Scholar 

  25. Parker JE, Shafi T, Pagliuca A, Mijovic A, Devereux S, Potter M et al. Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced-intensity conditioning compared with standard preparative regimens. Br J Haematol 2002; 119: 144–154.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Haematology, Nijmegen Medical Centre, Radboud University, Nijmegen, The Netherlands

    W J F M van der Velden, N M A Blijlevens & J P Donnelly

  2. Department of Epidemiology, Biostatistics and Health Technology Assessment, Nijmegen Medical Centre, Radboud University, Nijmegen, The Netherlands

    T Feuth

Authors
  1. W J F M van der Velden
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N M A Blijlevens
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T Feuth
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J P Donnelly
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W J F M van der Velden.

Rights and permissions

Reprints and permissions

About this article

Cite this article

van der Velden, W., Blijlevens, N., Feuth, T. et al. Febrile mucositis in haematopoietic SCT recipients. Bone Marrow Transplant 43, 55–60 (2009). https://doi.org/10.1038/bmt.2008.270

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.270

Keywords

Search

Advanced search

Quick links